Cargando…

Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis

BACKGROUND: Riociguat is a novel soluble guanylate cyclase stimulator, and has been widely used for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (CTEPH). Some studies found that riociguat had better effects on CTEPH and proved to be safe, but the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Miaofa, Song, Jin, Gu, Shenglong, Zhao, Rui, Li, Mingxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	6700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183702/ https://www.ncbi.nlm.nih.gov/pubmed/34087896 http://dx.doi.org/10.1097/MD.0000000000026211

Ejemplares similares

Microarray expression profile of circular RNAs in chronic thromboembolic pulmonary hypertension
por: Miao, Ran, et al.
Publicado: (2017)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Benza, Raymond L., et al.
Publicado: (2022)

Efficacy and safety of acupoint autohemotherapy in treating stable chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis
por: Hong, Haidu, et al.
Publicado: (2019)

CT-Base Pulmonary Artery Measurementin the Detection of Pulmonary Hypertension: A Meta-Analysis and Systematic Review
por: Shen, Yongchun, et al.
Publicado: (2014)

Efficacy and safety of Chuankezhi injection in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis protocol
por: Zhou, Zhihui, et al.
Publicado: (2020)

Correlation between right ventricular–pulmonary artery coupling and the prognosis of patients with pulmonary arterial hypertension
por: Nie, Lin, et al.
Publicado: (2019)

A case report of pulmonary thromboembolism following allergic bronchopulmonary aspergillosis
por: Pan, Ying, et al.
Publicado: (2020)

Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: A systematic review protocol
por: Yu, Mingxia, et al.
Publicado: (2019)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases
por: Baldi, Bruno Guedes, et al.
Publicado: (2021)

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
por: Kim, Nick H, et al.
Publicado: (2017)

Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis
por: Yin, Hong-lei, et al.
Publicado: (2017)

The impact and financial burden of pulmonary arterial hypertension on patients and caregivers: results from a national survey
por: Zhai, Zhenguo, et al.
Publicado: (2017)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
por: Marra, Alberto M., et al.
Publicado: (2018)

Prognostic significance of pulmonary hypertension in patients with cystic fibrosis: A systematic review and meta-analysis
por: Li, Diandian, et al.
Publicado: (2018)

The characteristics of the frequent exacerbators with chronic bronchitis phenotype and the asthma-chronic obstructive pulmonary disease overlap syndrome phenotype in chronic obstructive pulmonary disease patients: A meta-analysis and system review
por: Wu, Jian-Jun, et al.
Publicado: (2019)

Efficacy of exercise in patients with pulmonary fibrosis: A systematic review and meta-analysis
por: Gao, Yan, et al.
Publicado: (2022)

Pulmonary Hypertension Complicating Fibrosing Mediastinitis
por: Seferian, Andrei, et al.
Publicado: (2015)

Efficacy and safety of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis caused by novel coronavirus disease: A protocol for Bayesian network meta-analysis
por: Li, Feiran, et al.
Publicado: (2021)

Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension
por: van Thor, M.C.J., et al.
Publicado: (2019)

Effect of acupoint application on T lymphocyte subsets in patients with chronic obstructive pulmonary disease: A meta-analysis
por: Wu, Jian-Jun, et al.
Publicado: (2020)

Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
por: Sun, Tong, et al.
Publicado: (2016)

Investigation of the efficacy and pharmacological mechanism of Danhong injections for treating chronic obstructive pulmonary disease: A PRISMA-compliant meta-analysis and network pharmacology analysis
por: Gao, Xiaoyu, et al.
Publicado: (2023)

Effect of myrtol on chronic bronchitis or chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Liu, Liyun, et al.
Publicado: (2020)

Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center
por: Sulica, Roxana, et al.
Publicado: (2015)

The efficacy and safety of long-term add-on treatment of azithromycin in asthma: A systematic review and meta-analysis
por: Wang, Xiaohu, et al.
Publicado: (2019)

Efficacy and safety of methylprednisolone against acute respiratory distress syndrome: A systematic review and meta-analysis
por: Lv, Hai, et al.
Publicado: (2021)

Efficacy and safety of Chinese medicine for obstructive sleep apnea: A protocol for systematic review and meta-analysis
por: Bao, Jun-Li, et al.
Publicado: (2021)

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease is independently associated with hypertension in men: A survey design analysis using nationwide survey data
por: Kim, Seon-Hye, et al.
Publicado: (2017)

Effect of probiotics, prebiotics and synbiotics for chronic bronchitis or chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Pei, Caixia, et al.
Publicado: (2020)

Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
por: Wiedenroth, Christoph B., et al.
Publicado: (2018)

Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report
por: Sato, Shuji, et al.
Publicado: (2021)

Efficacy and safety of Chinese patent medicine injection for COVID-19: A protocol for systematic review and meta-analysis
por: Lu, Meiqi, et al.
Publicado: (2020)

The efficacy and safety of tezepelumab in the treatment of uncontrolled asthma: A systematic review and meta-analysis of randomized controlled trials
por: Lin, Fei, et al.
Publicado: (2023)

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
por: McLaughlin, Vallerie V., et al.
Publicado: (2017)

Body mass index and mortality in chronic obstructive pulmonary disease: A dose–response meta-analysis
por: Guo, Yibin, et al.
Publicado: (2016)

MMP-9-C1562T polymorphism and susceptibility to chronic obstructive pulmonary disease: A meta-analysis
por: Zhao, Rongrong, et al.
Publicado: (2020)

The Efficacy and Safety of Antiinterleukin 13, a Monoclonal Antibody, in Adult Patients With Asthma: A Systematic Review and Meta-Analysis
por: Luo, Jian, et al.
Publicado: (2016)

The efficacy and safety of osimertinib in treating nonsmall cell lung cancer: A PRISMA-compliant systematic review and meta-analysis
por: Liu, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jn971neme4b6d7qttegch1o37n